Microbiome Therapeutics Market Size, Share, Growth & industry Analysis, By Type (Drugs and FMT), By Application (C. difficile, Inflammatory Bowel Disease, Diabetes, Immuno-oncology, and Others), and Regional Analysis, 2024-2031

TABLE OF CONTENT

1 INTRODUCTION OF THE GLOBAL MICROBIOME THERAPEUTICS MARKET 
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL MICROBIOME THERAPEUTICS MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 IMPACT OF RUSSIA-UKRAINE WAR

6 GLOBAL MICROBIOME THERAPEUTICS MARKET, BY TYPE
6.1 Overview
6.2 Drugs
6.3 FMT 

7 GLOBAL MICROBIOME THERAPEUTICS MARKET, BY APPLICATION
7.1 Overview
7.2 C. difficile
7.3 Inflammatory Bowel Disease
7.4 Diabetes
7.5 Immuno-oncology
7.6 Others
8 GLOBAL MICROBIOME THERAPEUTICS MARKET, BY GEOGRAPHY
8.1 Overview

9 NORTH AMERICA 
9.1 U.S.
9.2 Canada
9.3 Mexico

10 EUROPE 
10.1 Germany
10.2 U.K.
10.3 France
10.4 Italy
10.5 Spain
10.6 Russia
10.7 Rest of Europe

11 ASIA-PACIFIC 
11.1 China
11.2 Japan
11.3 India
11.4 South Korea
11.5 Rest of Asia-Pacific

12 MIDDLE EAST & AFRICA 
12.1 GCC
12.2 South Africa
12.3 North Africa
12.4 Rest of Middle East & Africa

13 LATIN AMERICA 
13.1 Brazil
13.2 Argentina
13.3 Rest of South America

14 GLOBAL MICROBIOME THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
14.1 Overview
14.2 Key Developments
14.3 Key Strategic Developments
14.4 Company Market Ranking
14.5 Regional Footprint
14.6 Industry Footprint

15 COMPANY PROFILES
15.1 Seres Therapeutics 
15.1.1 Key Facts
15.1.2 Financial Overview
15.1.3 Product Benchmarking
15.1.4 Recent Developments
15.1.5 Winning Imperatives
15.1.6 Current Focus & Strategies
15.1.7 Threat from competition
15.1.8 SWOT Analysis
15.2 4D Pharma plc.
15.2.1 Key Facts
15.2.2 Financial Overview
15.2.3 Product Benchmarking
15.2.4 Recent Developments
15.2.5 Winning Imperatives
15.2.6 Current Focus & Strategies
15.2.7 Threat from competition
15.2.8 SWOT Analysis
15.3 Locus Biosciences, Inc.
15.3.1 Key Facts
15.3.2 Financial Overview
15.3.3 Product Benchmarking
15.3.4 Recent Developments
15.3.5 Winning Imperatives
15.3.6 Current Focus & Strategies
15.3.7 Threat from competition
15.3.8 SWOT Analysis
15.4 Enterome SA
15.4.1 Key Facts
15.4.2 Financial Overview
15.4.3 Product Benchmarking
15.4.4 Recent Developments
15.4.5 Winning Imperatives
15.4.6 Current Focus & Strategies
15.4.7 Threat from competition
15.4.8 SWOT Analysis
15.5 Finch Therapeutics Group, Inc.
15.5.1 Key Facts
15.5.2 Financial Overview
15.5.3 Product Benchmarking
15.5.4 Recent Developments
15.5.5 Winning Imperatives
15.5.6 Current Focus & Strategies
15.5.7 Threat from competition
15.5.8 SWOT Analysis
15.6 Intralytix, Inc.
15.6.1 Key Facts
15.6.2 Financial Overview
15.6.3 Product Benchmarking
15.6.4 Recent Developments
15.6.5 Winning Imperatives
15.6.6 Current Focus & Strategies
15.6.7 Threat from competition
15.6.8 SWOT Analysis
15.7 Microbiotica
15.7.1 Key Facts
15.7.2 Financial Overview
15.7.3 Product Benchmarking
15.7.4 Recent Developments
15.7.5 Winning Imperatives
15.7.6 Current Focus & Strategies
15.7.7 Threat from competition
15.7.8 SWOT Analysis
15.8 REBYOTA 
15.8.1 Key Facts
15.8.2 Financial Overview
15.8.3 Product Benchmarking
15.8.4 Recent Developments
15.8.5 Winning Imperatives
15.8.6 Current Focus & Strategies
15.8.7 Threat from competition
15.8.8 SWOT Analysis
15.9 Rebiotix Inc.
15.9.1 Key Facts
15.9.2 Financial Overview
15.9.3 Product Benchmarking
15.9.4 Recent Developments
15.9.5 Winning Imperatives
15.9.6 Current Focus & Strategies
15.9.7 Threat from competition
15.9.8 SWOT Analysis
15.10 Vedanta Bioscience, Inc.
15.10.1 Key Facts
15.10.2 Financial Overview
15.10.3 Product Benchmarking
15.10.4 Recent Developments
15.10.5 Winning Imperatives
15.10.6 Current Focus & Strategies
15.10.7 Threat from competition
15.10.8 SWOT Analysis

List of Tables

TABLE 1 Global Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 2 Global Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 3 Global Microbiome Therapeutics Market Revenue, By Geography, 2021 – 2031 (USD Million)
TABLE 4 North America Microbiome Therapeutics Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 5 North America Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 6 North America Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 7 US Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 8 US Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 9 Canada Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 10 Canada Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 11 Mexico Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 12 Mexico Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 13 Europe Microbiome Therapeutics Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 14 Europe Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 15 Europe Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 16 Germany Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 17 Germany Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 18 France Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 19 France Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 20 U.K. Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 21 U.K. Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 22 Spain Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 23 Spain Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 24 Italy Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 25 Italy Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 26 Russia Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 27 Russia Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 28 Rest of Europe Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 29 Rest of Europe Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 30 Asia-Pacific Microbiome Therapeutics Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 31 Asia-Pacific Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 32 Asia-Pacific Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 33 China Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 34 China Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 35 Japan Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 36 Japan Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 37 India Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 38 India Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 39 South Korea Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 40 South Korea Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 41 Rest of Asia-Pacific Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 42 Rest of Asia-Pacific Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 43 Middle East and Africa Microbiome Therapeutics Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 44 Middle East and Africa Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 45 Middle East and Africa Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 46 GCC Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 47 GCC Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 48 North Africa Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 49 North Africa Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 50 South Africa Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 51 South Africa Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 52 Rest of Middle East & Africa Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 53 Rest of Middle East & Africa Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 54 Latin America Microbiome Therapeutics Market Revenue, By Country, 2021 – 2031 (USD Million)
TABLE 55 Latin America Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 56 Latin America Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 57 Brazil Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 58 Brazil Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 59 Argentina Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 60 Argentina Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 61 Rest of Latin America Microbiome Therapeutics Market Revenue, By Type, 2021 – 2031 (USD Million)
TABLE 62 Rest of Latin America Microbiome Therapeutics Market Revenue, By Application, 2021 – 2031 (USD Million)
TABLE 63 Company Market Ranking
TABLE 64 Regional Footprint
TABLE 65 Product Benchmarking
TABLE 66 Recent Developments
TABLE 67 Winning Imperatives 

LIST OF FIGURES

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Microbiome Therapeutics Market 2021-2031 (USD Million)
FIG. 4 Global Microbiome Therapeutics Market Geographical Analysis (CAGR %)
FIG. 5 Global Microbiome Therapeutics Absolute Market Opportunity (USD Million)
FIG. 6 Global Microbiome Therapeutics Market Attractiveness (USD Million)
FIG. 7 Global Microbiome Therapeutics Market, By Type, 2021-2031 (USD Million)
FIG. 8 Global Microbiome Therapeutics Market, By Application, 2021-2031 (USD Million)
FIG. 9 Research Methodology
FIG. 10 Research Process
FIG. 11 Bottom-Up Approach
FIG. 12 Top-Bottom Approach
FIG. 13 Market Dynamics Overview
FIG. 14 Porter's Five Forces Analysis
FIG. 15 Value Chain Analysis
FIG. 16 Macroeconomic Analysis
FIG. 17 Global Microbiome Therapeutics Market Revenue Share, By Type, 2023 and 2031 (%)
FIG. 18 Global Microbiome Therapeutics Market Revenue Share, By Application, 2023 and 2031 (%)
FIG. 19 Global Microbiome Therapeutics Market Revenue Share, By Geographic Regions, 2023 and 2031 (%)
FIG. 20 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 21 North America Microbiome Therapeutics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 22 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 23 Europe Microbiome Therapeutics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 24 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 25 Asia-Pacific Microbiome Therapeutics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 26 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 27 Middle East & Africa Microbiome Therapeutics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 28 Market Size and Projections, 2021 - 2031 (USD Million)
FIG. 29 Latin America Microbiome Therapeutics Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 30 Key Strategic Development
FIG. 31 Key Facts
FIG. 32 Financial Overview
FIG. 33 SWOT Analysis